We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Professor Mark Beresford at Spire include:
I see outpatients for consultations in Bath, but treat with radiotherapy at the Spire Oncology Centre.
I am the chair of the network breast cancer site-specific group and regional lead for breast cancer trials. I am the founder and chair of the UK Breast Cancer Group which acts as a voice for breast cancer oncologists across the country, and also an executive committee member of the British Uro-oncology Group.
Other national roles include being an elected member of the breast and radiotherapy subgroups of the National Cancer Research Institute and an advisor on the Cancer Research UK population studies group.
Special Clinical Interests: Radiotherapy, chemotherapy and targeted therapies including Novel therapies for advanced breast cancer; exercise and immune response to chemotherapy; Prostate cancer biomarkers and Imaging response to treatment.
Consultant clinical oncologist and head of radiotherapy, Royal United Hospital Bath
Visiting senior lecturer, University of Bath
|Telephone||01454 456 500|
|Private secretary||Linda Vince|
|Private secretary telephone||01225 838 861|
|Private secretary firstname.lastname@example.org|
24 June 2019
Spire Manchester Hospital has been rated CQC ‘Outstanding’ overall following inspection in February 2019
24 September 2018
At Spire Hospitals we work with a number of leading orthopaedic consultants, specialising in the treatment of spinal con…